[PDF][PDF] Galectin-1: a link between tumor hypoxia and tumor immune privilege
QT Le, G Shi, H Cao, DW Nelson, Y Wang… - Journal of clinical …, 2005 - med.stanford.edu
QT Le, G Shi, H Cao, DW Nelson, Y Wang, EY Chen, S Zhao, C Kong, D Richardson…
Journal of clinical oncology, 2005•med.stanford.eduGalectin-1: A Link Between Tumor Hypoxia and Tumor Immune Privilege Page 1 Galectin-1: A
Link Between Tumor Hypoxia and Tumor Immune Privilege Quynh-Thu Le, Gongyi Shi, Hongbin
Cao, Daniel W. Nelson, Yingyun Wang, Eunice Y. Chen, Shuchun Zhao, Christina Kong, Donna
Richardson, Ken J. O’Byrne, Amato J. Giaccia, and Albert C. Koong From the Departments of
Radiation Oncology, Otolaryngology, and Pathology, Stanford University, Stanford, CA; and
the Departments of Oncology, Pathology, and Epidemiology, University Hospitals of Leicester …
Link Between Tumor Hypoxia and Tumor Immune Privilege Quynh-Thu Le, Gongyi Shi, Hongbin
Cao, Daniel W. Nelson, Yingyun Wang, Eunice Y. Chen, Shuchun Zhao, Christina Kong, Donna
Richardson, Ken J. O’Byrne, Amato J. Giaccia, and Albert C. Koong From the Departments of
Radiation Oncology, Otolaryngology, and Pathology, Stanford University, Stanford, CA; and
the Departments of Oncology, Pathology, and Epidemiology, University Hospitals of Leicester …
Purpose
To identify a 15-KDa novel hypoxia-induced secreted protein in head and neck squamous cell carcinomas (HNSCC) and to determine its role in malignant progression.
med.stanford.edu